["Bronchitis"-therapy today].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000628:therapy*; D005100:Expectorants / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007665:Ketotifen; D010276:Parasympatholytics / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D010880:Piperidines / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D000996:Antitussive Agents; D005100:Expectorants; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010880:Piperidines; D013876:Thiophenes; D014970:Xanthines; C008514:methylxanthine; D007665:Ketotifen
"Bronchitis"-Therapie heute.